Detailed explanation of the reference cost and different purchasing channels of Caposetinib Tablets (Caposetinib)

Capivasertib is a new type of targeted anti-cancer drug, mainly used to treat tumor patients with specific gene mutations or signaling pathway abnormalities. The drug has been launched in China, providing a new option for patients in need of targeted therapy. Due to its short time on the market, its domestic market price has not yet been fully clarified, but it will be included in the scope of medical insurance in 2026. Patients should consult the hospital pharmacy for the latest price and medication policies before purchasing.

In terms of cost, the specific domestic price of Carpiseti Tablets is not yet known, but based on overseas markets, the price of the original drug is relatively high. The common specifications of the European, American and Swiss versions of the original medicine are 200mg*64 tablets, and the price per box is about more than 60,000 yuan. For patients undergoing long-term treatment, the cost burden is heavier and financial planning needs to be done in advance.

In comparison, the price of generic Carpiseti Tablets produced by Lucius in Laos is significantly lower, with the same specifications costing about more than 3,000 yuan per box. The ingredients of generic drugs are basically the same as the original drugs, which can provide patients with affordable treatment options. However, when choosing generic drugs, patients should ensure that they are purchased through formal channels to avoid quality issues that may affect the treatment effect.

Generally speaking, Carpisete tablets are sold both at home and abroad, but the prices vary greatly. Patients should fully consider their own financial situation when purchasing drugs, give priority to regular hospital or pharmacy channels to ensure the safety and reliability of drug sources, and pay attention to subsequent policy changes to obtain the latest price and reimbursement information in a timely manner.

Reference materials:https://pubmed.ncbi.nlm.nih.gov/38388873/